WOLLENBERG, A.; DE BRUIN-WELLER, M.; THYSSEN, J. P.; BECK, L. A.; SIMPSON, E. L.; IMAFUKU, S.; BOGUNIEWICZ, M.; KURBASIC, A.; SOLDBRO, L.; STRANGE VEST, N.; ARLERT, P.; PALLER, A. S. Conjunctivitis in adolescent patients aged 12–17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s75, 2022. DOI: 10.25251/skin.6.supp.75. Disponível em: https://jofskin.org/index.php/skin/article/view/1832. Acesso em: 22 jul. 2024.